Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Certara launches Cardiac Safety Simulator to determine arrhythmia risk for drug candidates
October 2013
by Bruce Poorman  |  Email the author
SHARING OPTIONS:


Certara
 
Based on an in-silico model of human ventricular heart cells, Certara's Cardiac Safety Simulator (CSS) helps sponsors to assess arrhythmia risk before a new drug candidate enters clinical trials and determine safe drug doses for specific patient populations.
 
Certara
www.certara.com   
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.